Personal information

No personal information available

Activities

Collapse all

Employment (1)

Tokyo Metropolitan Children's Medical Center: Tokyo, JP

2016-04 to present | Chief Consultant (Department of Hematology/Oncology)
Employment
Source: Self-asserted source
YUKI YUZA

Works (50 of 88)

Items per page:
Page 1 of 2

Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan.

Cancers
2024-04-15 | Journal article
DOI: 10.3390/cancers16081504
PMID: 38672586
PMC: PMC11048180
Contributors: Marin Ishikawa; Kohei Nakamura; Kawano R; Hayashi H; Ikeda T; Makoto Saito; Yo Niida; Jiichiro Sasaki; Okuda H; Ishihara S et al.
Source: Self-asserted source
YUKI YUZA

Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial.

International journal of clinical oncology
2024-04-02 | Journal article
DOI: 10.1007/s10147-024-02489-0
PMID: 38564107
Contributors: matsui motohiro; Makimoto A; Chin M; Koh K; Tomotsune M; Kaneko T; Morikawa Y; Hamada R; Yuza Y
Source: Self-asserted source
YUKI YUZA

Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients.

Haematologica
2024-04-01 | Journal article
DOI: 10.3324/haematol.2023.282914
PMID: 37881853
Contributors: Hangai M; Kawaguchi T; Takagi M; Matsuo K; Jeon S; Chiang CWK; Dewan AT; De Smith AJ; Imamura T; Okamoto Y et al.
Source: Self-asserted source
YUKI YUZA

False-Positive Asymmetrical Tongue Muscle 18F-FDG Uptake in Hypoglossal Nerve Paralysis Following Lymph Node Dissection in a Pediatric Patient with Malignant Rhabdoid Tumor of the Neck.

Children (Basel, Switzerland)
2024-03-15 | Journal article
DOI: 10.3390/children11030348
PMID: 38539383
PMC: PMC10969149
Contributors: Matsumoto Y; matsui motohiro; Makidono A; Atsushi Makimoto; Yuza Y
Source: Self-asserted source
YUKI YUZA

Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective.

Cancers
2024-02-08 | Journal article
DOI: 10.3390/cancers16040723
PMID: 38398113
PMC: PMC10887299
Contributors: Hiroshi Hayashi; Atsushi Makimoto; Yuza Y
Source: Self-asserted source
YUKI YUZA

Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects.

Cancers
2024-01-26 | Journal article
DOI: 10.3390/cancers16030544
PMID: 38339295
PMC: PMC10854948
Contributors: Atsushi Makimoto; Fujisaki H; Matsumoto K; Takahashi Y; Cho Y; Morikawa Y; Yuza Y; Tajiri T; tomoko
Source: Self-asserted source
YUKI YUZA

Inter-reporter differences in symptom burdens in Japanese children with cancer.

Pediatrics international : official journal of the Japan Pediatric Society
2024-01-01 | Journal article
DOI: 10.1111/ped.15729
PMID: 38409898
Contributors: Tomomi Hayase; Mieno MN; Mori N; Yuza Y; Hirozumi Sano; Osone S; Hasegawa D; Ashiarai M; Fukushima K
Source: Self-asserted source
YUKI YUZA

Myeloproliferative disorder in a patient with RIT1-associated Noonan syndrome: Case report and literature review.

Pediatric blood & cancer
2023-11-27 | Journal article
DOI: 10.1002/pbc.30780
PMID: 38015090
Contributors: Kyogo Suzuki; Wakamatsu M; Ito Y; Ishikawa M; Akihiro Shimotakahara; Futagawa H; Yusuke Yamamoto; Nagamine H; Saito O; Muramatsu H et al.
Source: Self-asserted source
YUKI YUZA

Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Annals of hematology
2023-11-25 | Journal article
DOI: 10.1007/s00277-023-05557-z
PMID: 38006571
Contributors: Ishida H; Arakawa Y; Hasegawa D; Usami I; Hashii Y; Yasuyuki Arai; Nishiwaki S; Keino D; Kato K; Sato M et al.
Source: Self-asserted source
YUKI YUZA

Adverse Events in Pediatric Inpatients: The Japan Adverse Event Study.

Journal of patient safety
2023-11-06 | Journal article
DOI: 10.1097/pts.0000000000001180
PMID: 37922224
Contributors: Sakuma M; Ohta Y; Takeuchi J; Yuza Y; Ida H; Bates DW; Morimoto T
Source: Self-asserted source
YUKI YUZA

High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia.

Leukemia
2023-11-06 | Journal article
DOI: 10.1038/s41375-023-02075-9
PMID: 37926712
Contributors: Daisuke Tomizawa; Jun Matsubayashi; Shotaro Iwamoto; Hidefumi Hiramatsu; Daisuke Hasegawa; Hiroshi Moritake; Hasegawa D; Kiminori Terui; Asahito Hama; Shin-ichi Tsujimoto et al.
Source: Self-asserted source
YUKI YUZA

Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11.

Transplantation and cellular therapy
2023-10-07 | Journal article
DOI: 10.1016/j.jtct.2023.10.002
PMID: 37806448
Contributors: Sakashita K; Yoshida N; Muramatsu H; Ohtsuka Y; Watanabe K; Yabe M; Kakuda H; Yuko Honda; Watanabe T; Haba M et al.
Source: Self-asserted source
YUKI YUZA

Challenges to Widespread Use of Fertility Preservation Facilities for Pediatric Cancer Patients in Japan.

Journal of adolescent and young adult oncology
2023-08-03 | Journal article
DOI: 10.1089/jayao.2023.0059
PMID: 37535825
Contributors: Tadashi Maezawa; Suzuki Nao; Takeuchi H; Nishioka M; Hidaka M; Manabe A; Koga Y; Hiroshi Kawaguchi; Sasahara Y; Tachibana M et al.
Source: Self-asserted source
YUKI YUZA

Transient myelodysplasia triggered by parvovirus B19 infection in a male with inborn error of bile acid metabolism.

Pediatric blood & cancer
2023-06-05 | Journal article
DOI: 10.1002/pbc.30486
PMID: 37277695
Contributors: Hiroshi Hayashi; Tanaka K; Inui A; Nittono H; Imagawa K; Kawakami M; Yuza Y
Source: Self-asserted source
YUKI YUZA

Rare <i>TCF3</i> variants associated with pediatric B cell acute lymphoblastic leukemia.

Pediatric hematology and oncology
2023-05-02 | Journal article
DOI: 10.1080/08880018.2023.2201302
PMID: 37129918
Contributors: Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Takeshi Inukai et al.
Source: Self-asserted source
YUKI YUZA

Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.

Cancer medicine
2023-04-06 | Journal article
DOI: 10.1002/cam4.5835
PMID: 37021926
PMC: PMC10242325
Contributors: Yoshida M; Nakabayashi K; Yang W; Sato-Otsubo A; Tsujimoto SI; Ogata-Kawata H; Kawai T; Ishiwata K; Sakamoto M; Okamura K et al.
Source: Self-asserted source
YUKI YUZA

A Fatal Case of Neuroblastoma Complicated by Posterior Reversible Encephalopathy with Rapidly Evolving Transplantation-Associated Thrombotic Microangiopathy.

Children (Basel, Switzerland)
2023-03-03 | Journal article
DOI: 10.3390/children10030506
PMID: 36980064
PMC: PMC10047442
Contributors: matsui motohiro; Atsushi Makimoto; Saito Y; Mikako Enokizono; Matsuoka K; Yuza Y
Source: Self-asserted source
YUKI YUZA

Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy.

Frontiers in oncology
2023-01-30 | Journal article
DOI: 10.3389/fonc.2023.1003633
PMID: 36793598
PMC: PMC9924065
Contributors: Fukaya Y; Kimura T; Hamada Y; Yoshimura K; Hiraga H; Yuza Y; Ogawa A; Hara J; Koh K; Kikuta A et al.
Source: Self-asserted source
YUKI YUZA

Role of Peer Support in Posttraumatic Growth Among Adolescent and Young Adult Cancer Patients and Survivors.

Journal of adolescent and young adult oncology
2022-12-28 | Journal article
DOI: 10.1089/jayao.2022.0064
PMID: 36579948
Contributors: matsui motohiro; Taku K; Tsutsumi R; Ueno M; Seto M; Makimoto A; Yuza Y
Source: Self-asserted source
YUKI YUZA

Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome.

International journal of hematology
2022-12-14 | Journal article
DOI: 10.1007/s12185-022-03505-7
PMID: 36515795
PMC: PMC10063491
Contributors: Irie M; Niihori T; Nakano T; Suzuki T; Katayama S; Moriya K; Hidetaka Niizuma; Suzuki N; Saito-Nanjo Y; Onuma M et al.
Source: Self-asserted source
YUKI YUZA

Clinical characteristics and treatment of IMP-type carbapenemase-producing Enterobacteriaceae bacteremia: Case series and literature review.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2022-09-12 | Journal article
DOI: 10.1016/j.jiac.2022.09.003
PMID: 36100144
Contributors: Soneda K; Uda K; Kotaro Araki; Murakoshi T; Yuza Y; Saito O; Kinoshita K; Higuchi H; Horikoshi Y
Source: Self-asserted source
YUKI YUZA

Information needs of children with leukemia and their parents' perspectives of their information needs: a qualitative study.

BMC pediatrics
2022-07-13 | Journal article
DOI: 10.1186/s12887-022-03478-w
PMID: 35831839
PMC: PMC9277964
Contributors: Yamaji N; Nagamatsu Y; Kyoko Kobayashi; Daisuke Hasegawa; Yuza Y; Ota E
Source: Self-asserted source
YUKI YUZA

Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.

Pediatric blood & cancer
2022-04-11 | Journal article
DOI: 10.1002/pbc.29699
PMID: 35403816
Contributors: Haruko Shima; Kada A; Akihiko Tanizawa; Iori Sato; Tono C; Ito M; Yuza Y; Watanabe A; Kamibeppu K; Uryu H et al.
Source: Self-asserted source
YUKI YUZA

Pharyngolaryngeal Hematomas in Hemophilia A.

The New England journal of medicine
2022-02-12 | Journal article
DOI: 10.1056/nejmicm2114162
PMID: 35148039
Contributors: Kida W; Yuza Y
Source: Self-asserted source
YUKI YUZA

Reliability and Validity of the Japanese Pediatric Version of Memorial Symptom Assessment Scale.

Journal of pain and symptom management
2022-01-11 | Journal article
DOI: 10.1016/j.jpainsymman.2021.12.029
PMID: 35031501
Contributors: Hayase T; Mieno MN; Kyoko Kobayashi; Naoko Mori; Adam Lebowitz; Kato Y; Saito Y; Yuza Y; Hirozumi Sano; Shinya Osone et al.
Source: Self-asserted source
YUKI YUZA

NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.

Blood advances
2021-12-01 | Journal article
DOI: 10.1182/bloodadvances.2021005507
PMID: 34662904
PMC: PMC9153020
Contributors: Masanori Yoshida; Nakabayashi K; Yang W; Sato-Otsubo A; Shin-ichi Tsujimoto; Hiroko Ogata-Kawata; Tomoko Kawai; Ishiwata K; Mika Sakamoto; Kohji OKAMURA et al.
Source: Self-asserted source
YUKI YUZA

Successful High-dose Chemotherapy in Combination With Autologous Peripheral Blood Stem Cell Transplantation in an Anuric Child With Neuroblastoma.

Journal of pediatric hematology/oncology
2021-11-01 | Journal article
DOI: 10.1097/mph.0000000000002090
PMID: 33625080
Contributors: Inoguchi T; Hamada R; Kubota W; Terano C; Harada R; Honda M; Yamaoka S; Yokokawa Y; Yuza Y; Hataya H
Source: Self-asserted source
YUKI YUZA

[Tumor Lysis Syndrome-Up to Date].

Gan to kagaku ryoho. Cancer & chemotherapy
2021-09-01 | Journal article
PMID: 34521781
Contributors: Yuza Y
Source: Self-asserted source
YUKI YUZA

Phase III study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in pediatric patients.

Japanese journal of clinical oncology
2021-08-01 | Journal article
DOI: 10.1093/jjco/hyab079
PMID: 34021341
Contributors: Hara J; Kosaka Y; Koh K; Matsumoto K; Kumamoto T; Fujisaki H; Ishida Y; Suzuki R; Mochizuki S; Goto H et al.
Source: Self-asserted source
YUKI YUZA

Predictive factors of acute respiratory events during initial induction chemotherapy in patients with advanced neuroblastoma.

Cancer reports (Hoboken, N.J.)
2021-07-13 | Journal article
DOI: 10.1002/cnr2.1499
PMID: 34255936
PMC: PMC9124507
Contributors: matsui motohiro; Atsushi Makimoto; Nishio N; Takahashi Y; Urashima M; Yuza Y
Source: Self-asserted source
YUKI YUZA

Correction: Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.

Bone marrow transplantation
2021-05-01 | Journal article
DOI: 10.1038/s41409-020-01076-x
PMID: 33057144
Contributors: Koyamaishi S; Kamio T; Kobayashi A; Sato T; Ko Kudo; Sasaki S; Kanezaki R; Daiichiro Hasegawa; Hideki Muramatsu; Takahashi Y et al.
Source: Self-asserted source
YUKI YUZA

Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.

Bone marrow transplantation
2021-04-28 | Journal article
DOI: 10.1038/s41409-021-01303-z
PMID: 33911201
Contributors: Yuya Saito; Urashima M; Takahashi Y; Ogawa A; Kiyotani C; Yuza Y; Koh K; Watanabe K; Kosaka Y; Goto H et al.
Source: Self-asserted source
YUKI YUZA

Tumor-Treating Fields Therapy for Pediatric Brain Tumors.

Neurology international
2021-04-08 | Journal article
DOI: 10.3390/neurolint13020015
PMID: 33917660
PMC: PMC8167650
Contributors: Atsushi Makimoto; Nishikawa R; Terashima K; Jun Kurihara; Fujisaki H; Ihara S; Yoshihiko Morikawa; Yuza Y
Source: Self-asserted source
YUKI YUZA

Cardiovascular toxicity of regorafenib for heavily-treated osteosarcoma.

Pediatrics international : official journal of the Japan Pediatric Society
2020-12-05 | Journal article
DOI: 10.1111/ped.14503
PMID: 33277804
Contributors: Yuya Saito; Atsushi Makimoto; Masaru Miura; Yuza Y
Source: Self-asserted source
YUKI YUZA

123I-metaiodobenzylguanidine (MIBG)-positive testicular mass in a neuroblastoma.

Pediatrics international : official journal of the Japan Pediatric Society
2020-12-03 | Journal article
DOI: 10.1111/ped.14344
PMID: 33270314
Contributors: Atsushi Harada; Atsushi Makimoto; Shimojima N; Yuza Y; Hirobe S
Source: Self-asserted source
YUKI YUZA

The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.

Pediatric blood & cancer
2020-09-29 | Journal article
DOI: 10.1002/pbc.28736
PMID: 32991072
Contributors: Hiroshi Moritake; Shiro Tanaka; Takako Miyamura; Hideki Nakayama; Norio Shiba; Shimada A; Kiminori Terui; Yuza Y; Koh K; Goto H et al.
Source: Self-asserted source
YUKI YUZA

Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.

Bone marrow transplantation
2020-09-18 | Journal article
DOI: 10.1038/s41409-020-01056-1
PMID: 32948829
Contributors: Koyamaishi S; Kamio T; Kobayashi A; Sato T; Ko Kudo; Sasaki S; Kanezaki R; Daiichiro Hasegawa; Hideki Muramatsu; Takahashi Y et al.
Source: Self-asserted source
YUKI YUZA

Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide and Antithymocyte Globulin from HLA-Mismatched Related Donors for Nonmalignant Diseases.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2020-08-14 | Journal article
DOI: 10.1016/j.bbmt.2020.08.008
PMID: 32798657
Contributors: Tomoo Osumi; Yoshimura S; Sako M; Uchiyama T; Takashi Ishikawa; Toshinao Kawai; Inoue E; Takimoto T; Takeuchi I; Yamada M et al.
Source: Self-asserted source
YUKI YUZA

Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.

Genes, chromosomes & cancer
2020-07-16 | Journal article
DOI: 10.1002/gcc.22858
PMID: 32368831
Contributors: Kentaro Ohki; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H et al.
Source: Self-asserted source
YUKI YUZA

Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.

Pediatrics international : official journal of the Japan Pediatric Society
2020-06-04 | Journal article
DOI: 10.1111/ped.14172
PMID: 32495974
Contributors: Naoki Kajita; Yuya Saito; Atsushi Makimoto; Satoshi Miyahara; Yuza Y
Source: Self-asserted source
YUKI YUZA

Genetic Profile and Microsatellite Instability in a Case of Secondary Esophageal Squamous Cell Carcinoma 12 Years After Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia.

Journal of pediatric hematology/oncology
2020-05-01 | Journal article
DOI: 10.1097/mph.0000000000001355
PMID: 30499911
Contributors: Akiyama M; Yamaoka M; Ohyama W; Yokoi K; Ashizuka S; Aizawa D; Ikegami M; Suzuki H; Ozaki K; Ida H et al.
Source: Self-asserted source
YUKI YUZA

Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: A protocol for a randomized phase 2 trial.

Contemporary clinical trials communications
2019-08-22 | Journal article
DOI: 10.1016/j.conctc.2019.100440
PMID: 31508533
PMC: PMC6722396
Contributors: Atsushi Makimoto; Matsui M; Chin M; Koh K; Tomotsune M; Tetsuji Kaneko; Yoshihiko Morikawa; Yuza Y
Source: Self-asserted source
YUKI YUZA

Initial Symptoms of Langerhans Cell Histiocytosis: A Case Series.

Global pediatric health
2019-06-19 | Journal article
DOI: 10.1177/2333794x19857377
PMID: 31259209
PMC: PMC6585240
Contributors: Yukari Atsumi; Saito Y; Hataya H; Yuza Y
Source: Self-asserted source
YUKI YUZA

Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2019-04-17 | Journal article
DOI: 10.1016/j.bbmt.2019.04.014
PMID: 31002992
Contributors: Hangai M; Urayama KY; Tanaka J; Kato K; Nishiwaki S; Koh K; Noguchi M; Kato K; Yoshida N; Sato M et al.
Source: Self-asserted source
YUKI YUZA

Pediatric oncologic emergencies: Clinical and imaging review for pediatricians.

Pediatrics international : official journal of the Japan Pediatric Society
2019-02-07 | Journal article
DOI: 10.1111/ped.13755
PMID: 30565795
Contributors: Atsuhiko Handa; Taiki Nozaki; Makidono A; Okabe T; Yuka Morita; Fujita K; Matsusako M; Kono T; Kurihara Y; Daisuke Hasegawa et al.
Source: Self-asserted source
YUKI YUZA

Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan.

International journal of hematology
2019-01-29 | Journal article
DOI: 10.1007/s12185-019-02601-5
PMID: 30694451
Contributors: Nozomu Kawashima; Iida M; Ritsuro Suzuki; Fukuda T; Atsuta Y; Hashii Y; Inoue M; Kobayashi M; Yabe H; Okada K et al.
Source: Self-asserted source
YUKI YUZA

Ewing's Sarcoma with Extension into Superior Vena Cava and Right Atrium.

Indian journal of surgical oncology
2019-01-03 | Journal article
DOI: 10.1007/s13193-018-0849-0
PMID: 30948882
PMC: PMC6414591
Contributors: Atsumi Y; Saito Y; Hataya H; Fukuzawa R; Yuza Y
Source: Self-asserted source
YUKI YUZA

Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Pediatric blood & cancer
2018-08-07 | Journal article
DOI: 10.1002/pbc.27368
PMID: 30084127
Contributors: Kurosawa H; Akihiko Tanizawa; Hideki Muramatsu; Tono C; Watanabe A; Haruko Shima; Ito M; Yuza Y; Hamamoto K; Hotta N et al.
Source: Self-asserted source
YUKI YUZA

Kidney-protective Effect of Magnesium Supplementation in Cisplatin-containing Chemotherapy for Pediatric Cancer: A Retrospective Study.

Journal of pediatric hematology/oncology
2018-07-01 | Journal article
DOI: 10.1097/mph.0000000000001159
PMID: 29683958
Contributors: Matsui M; Saito Y; Yamaoka S; Yokokawa Y; Yoshihiko Morikawa; Makimoto A; Yuza Y
Source: Self-asserted source
YUKI YUZA

Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.

Bone marrow transplantation
2018-05-24 | Journal article
DOI: 10.1038/s41409-018-0221-6
PMID: 29795428
Contributors: Motohiro Kato; Kurata M; Junya Kanda; Kato K; Daisuke Tomizawa; Kudo K; Yoshida N; Watanabe K; Shimada H; Inagaki J et al.
Source: Self-asserted source
YUKI YUZA
Items per page:
Page 1 of 2
How many people are using ORCID?